Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Risk factors associated with severe outcomes of COVID-19: A systematic rapid review to inform national guidance on vaccine prioritization in Canada

Michelle Gates, Jennifer Pillay, Aireen Wingert, Samantha Guitard, Sholeh Rahman, Bernadette Zakher, Allison Gates, Lisa Hartling
doi: https://doi.org/10.1101/2021.04.23.21256014
Michelle Gates
1Alberta Research Centre for Health Evidence, University of Alberta, Room 4-496 A, 4th Floor Edmonton Clinic Health Academy, 11405-87 Avenue, Edmonton, Alberta, Canada, T6G 1C9
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: michellegates85@gmail.com
Jennifer Pillay
1Alberta Research Centre for Health Evidence, University of Alberta, Room 4-496 A, 4th Floor Edmonton Clinic Health Academy, 11405-87 Avenue, Edmonton, Alberta, Canada, T6G 1C9
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aireen Wingert
1Alberta Research Centre for Health Evidence, University of Alberta, Room 4-496 A, 4th Floor Edmonton Clinic Health Academy, 11405-87 Avenue, Edmonton, Alberta, Canada, T6G 1C9
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samantha Guitard
1Alberta Research Centre for Health Evidence, University of Alberta, Room 4-496 A, 4th Floor Edmonton Clinic Health Academy, 11405-87 Avenue, Edmonton, Alberta, Canada, T6G 1C9
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sholeh Rahman
1Alberta Research Centre for Health Evidence, University of Alberta, Room 4-496 A, 4th Floor Edmonton Clinic Health Academy, 11405-87 Avenue, Edmonton, Alberta, Canada, T6G 1C9
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bernadette Zakher
1Alberta Research Centre for Health Evidence, University of Alberta, Room 4-496 A, 4th Floor Edmonton Clinic Health Academy, 11405-87 Avenue, Edmonton, Alberta, Canada, T6G 1C9
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Allison Gates
1Alberta Research Centre for Health Evidence, University of Alberta, Room 4-496 A, 4th Floor Edmonton Clinic Health Academy, 11405-87 Avenue, Edmonton, Alberta, Canada, T6G 1C9
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lisa Hartling
1Alberta Research Centre for Health Evidence, University of Alberta, Room 4-496 A, 4th Floor Edmonton Clinic Health Academy, 11405-87 Avenue, Edmonton, Alberta, Canada, T6G 1C9
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Background To inform vaccine prioritization guidance in Canada, we systematically reviewed evidence on the magnitude of association between risk factors and severe outcomes of COVID-19. The urgent nature of this review necessitated an adapted methodology, which may serve as an exemplar for reviews undertaken under strict timelines.

Methods We updated our existing review by searching online databases and websites for cohort studies providing multivariate adjusted associations. After piloting, one author screened studies and extracted data. Two authors estimated the magnitude of association between exposures and outcomes as little-to-no (odds, risk, or hazard ratio <2.0, or >0.50 for reduction), large (2.0-3.9, or 0.50-0.26 for reduction), or very large (≥4.0, or ≤0.25 for reduction), and rated the evidence certainty using GRADE.

Results Of 11,734 unique records we included 134 reports. There is probably (moderate certainty) at least a large increase in mortality from COVID-19 among people aged 60-69 vs. <60 years (11 studies, n=517,217), with ≥2 vs. no comorbidities (4 studies, n=189,608), and for people with (vs. without): Down syndrome (1 study, n>8 million), type 1 and 2 diabetes (1 study, n>8 million), end-stage kidney disease (1 study, n>8 million), motor neuron disease, multiple sclerosis, myasthenia gravis, or Huntington’s disease (as a grouping; 1 study, n>8 million). The magnitude of association with mortality is probably very large for Down syndrome and may (low certainty) be very large for age 60-69 years, and diabetes. There is probably little-to-no increase in severe outcomes with several cardiovascular and respiratory conditions, and for adult males vs. females.

Conclusion There is strong evidence to support at least a large increase in mortality from COVID-19 among older adults aged 60 to 69 years versus <60 years; people having two or more versus no comorbidities; and for people affected by several pre-existing conditions. The methodology employed in this review may provide an important exemplar for future syntheses undertaken under urgent timelines.

Systematic review registration PROSPERO #CRD42021230185.

Competing Interest Statement

Michelle Gates and Allison Gates are employees of the Canadian Agency for Drugs and Technologies in Health (CADTH). The current work was unrelated to their employment and CADTH had no role in the funding, design, or oversight of the work.

Funding Statement

TThis study was completed under contract to the Public Health Agency of Canada, contract #4600001536. LH is supported by a Tier 1 Canada Research Chair in knowledge synthesis and translation. The funders had no role in the design of the study, data collection and analysis, preparation of the manuscript, nor decision to submit for publication.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethics approval was not required because this is a systematic review.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Minor edits based on comments received from reviewers.

Data Availability

The data pertaining to the conclusions are available on reasonable request using the following link: https://doi.org/10.7939/DVN/W1M6OP.

https://doi.org/10.7939/DVN/W1M6OP

  • LIST OF ABBREVIATIONS

    aOR
    adjusted odds ratio
    BMI
    body mass index
    COVID-19
    novel coronavirus disease 2019
    ICU
    intensive care unit
    RT-PCR
    reverse transcription polymerase chain reaction
    NACI
    National Advisory Committee on Immunization
    OECD
    Organization for Economic Cooperation and Development
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted November 28, 2021.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Risk factors associated with severe outcomes of COVID-19: A systematic rapid review to inform national guidance on vaccine prioritization in Canada
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Risk factors associated with severe outcomes of COVID-19: A systematic rapid review to inform national guidance on vaccine prioritization in Canada
    Michelle Gates, Jennifer Pillay, Aireen Wingert, Samantha Guitard, Sholeh Rahman, Bernadette Zakher, Allison Gates, Lisa Hartling
    medRxiv 2021.04.23.21256014; doi: https://doi.org/10.1101/2021.04.23.21256014
    Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
    Citation Tools
    Risk factors associated with severe outcomes of COVID-19: A systematic rapid review to inform national guidance on vaccine prioritization in Canada
    Michelle Gates, Jennifer Pillay, Aireen Wingert, Samantha Guitard, Sholeh Rahman, Bernadette Zakher, Allison Gates, Lisa Hartling
    medRxiv 2021.04.23.21256014; doi: https://doi.org/10.1101/2021.04.23.21256014

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Infectious Diseases (except HIV/AIDS)
    Subject Areas
    All Articles
    • Addiction Medicine (161)
    • Allergy and Immunology (414)
    • Anesthesia (90)
    • Cardiovascular Medicine (857)
    • Dentistry and Oral Medicine (159)
    • Dermatology (97)
    • Emergency Medicine (248)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (393)
    • Epidemiology (8556)
    • Forensic Medicine (4)
    • Gastroenterology (383)
    • Genetic and Genomic Medicine (1747)
    • Geriatric Medicine (167)
    • Health Economics (372)
    • Health Informatics (1239)
    • Health Policy (620)
    • Health Systems and Quality Improvement (467)
    • Hematology (196)
    • HIV/AIDS (372)
    • Infectious Diseases (except HIV/AIDS) (10290)
    • Intensive Care and Critical Care Medicine (553)
    • Medical Education (192)
    • Medical Ethics (51)
    • Nephrology (211)
    • Neurology (1676)
    • Nursing (97)
    • Nutrition (248)
    • Obstetrics and Gynecology (326)
    • Occupational and Environmental Health (450)
    • Oncology (928)
    • Ophthalmology (263)
    • Orthopedics (101)
    • Otolaryngology (172)
    • Pain Medicine (112)
    • Palliative Medicine (40)
    • Pathology (252)
    • Pediatrics (534)
    • Pharmacology and Therapeutics (248)
    • Primary Care Research (207)
    • Psychiatry and Clinical Psychology (1765)
    • Public and Global Health (3834)
    • Radiology and Imaging (623)
    • Rehabilitation Medicine and Physical Therapy (319)
    • Respiratory Medicine (520)
    • Rheumatology (208)
    • Sexual and Reproductive Health (165)
    • Sports Medicine (158)
    • Surgery (190)
    • Toxicology (36)
    • Transplantation (101)
    • Urology (76)